These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27630294)

  • 1. Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma.
    DO Carmo NG; Sakamoto LH; Pogue R; DO Couto Mascarenhas C; Passos SK; Felipe MS; DE Andrade RV
    Anticancer Res; 2016 Sep; 36(9):4545-51. PubMed ID: 27630294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
    Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
    J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
    Shi FT; Yu M; Zloty D; Bell RH; Wang E; Akhoundsadegh N; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
    Mol Med Rep; 2017 Apr; 15(4):1441-1454. PubMed ID: 28259916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
    Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
    Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
    O'Driscoll L; McMorrow J; Doolan P; McKiernan E; Mehta JP; Ryan E; Gammell P; Joyce H; O'Donovan N; Walsh N; Clynes M
    Mol Cancer; 2006 Dec; 5():74. PubMed ID: 17173689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
    Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
    BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
    Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
    Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation.
    Tanese K; Fukuma M; Yamada T; Mori T; Yoshikawa T; Watanabe W; Ishiko A; Amagai M; Nishikawa T; Sakamoto M
    Am J Pathol; 2008 Sep; 173(3):835-43. PubMed ID: 18688030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
    Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma.
    Noubissi FK; Yedjou CG; Spiegelman VS; Tchounwou PB
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29987229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
    Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
    Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
    Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX3 protein is overexpressed in human basal cell carcinomas.
    Salto-Tellez M; Peh BK; Ito K; Tan SH; Chong PY; Han HC; Tada K; Ong WY; Soong R; Voon DC; Ito Y
    Oncogene; 2006 Dec; 25(58):7646-9. PubMed ID: 16767156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma.
    Bozdogan O; Yulug IG; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N
    Int J Dermatol; 2015 Aug; 54(8):905-15. PubMed ID: 25428551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CRD-BP in the growth of human basal cell carcinoma cells.
    Noubissi FK; Kim T; Kawahara TN; Aughenbaugh WD; Berg E; Longley BJ; Athar M; Spiegelman VS
    J Invest Dermatol; 2014 Jun; 134(6):1718-1724. PubMed ID: 24468749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.